TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroxyperoxycyclophosphamide in vitro

  • R. M. Lemoli
  • , A. Strife
  • , B. D. Clarkson
  • , J. D. Haley
  • , S. C. Gulati

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroxyperoxycyclophosphamide in vitro'. Together they form a unique fingerprint.

Immunology and Microbiology

Keyphrases

Medicine and Dentistry

Neuroscience

Veterinary Science and Veterinary Medicine

Pharmacology, Toxicology and Pharmaceutical Science